| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |